コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 mycin or the selective olfactotoxic chemical methimazole.
2 e form with a structure analogous to that of methimazole.
3 s as the thyroid hormone synthesis inhibitor methimazole.
4 ts who were treated with propylthiouracil or methimazole.
5 and treated with either propylthiouracil or methimazole.
6 ty, and is treated with propylthiouracil and methimazole.
10 ntacular cells, and both naris occlusion and methimazole altered the abundance of the antibacterial l
11 e guidelines recommend propylthiouracil over methimazole, although the difference in outcomes associa
12 ith two selective functional FMO substrates, methimazole, and 10-(N,N-dimethylaminopentyl)-2-(trifluo
14 with propylthiouracil and those treated with methimazole, assessed by targeted maximum likelihood est
15 Combined, the results indicate that phenyl methimazole can reduce TNF-alpha-induced VCAM-1 expressi
17 trast, imipramine inhibits the metabolism of methimazole catalyzed by pig FMO1 at all substrate conce
18 i-thyroid hormone drugs (propylthiouracil or methimazole) completely rescues SMRT-induced RDS, sugges
19 sis that a derivative of methimazole, phenyl methimazole (compound 10), can reduce cytokine-induced E
20 tabolism catalyzed by rabbit FMO1 or FMO2 at methimazole concentrations greater than 50 or 100 microM
22 (46 of 727; 95% CI, 4.6%-8.1%) who initiated methimazole died in the hospital (adjusted risk differen
23 a previous report, the selenium analogue of methimazole exists in the selone form with a structure a
24 uidelines recommending propylthiouracil over methimazole for treatment of thyroid storm may merit ree
29 oxidase and deiodinase inhibition potencies (methimazole, iopanoic acid, and propylthiouracil) to eva
30 um, by combining targeted DIO3 knockdown and methimazole, led to corresponding changes in tectal cell
31 women [72.1%]; and 727 [52.6%] treated with methimazole; mean [SD] age, 45 [16] years; 520 women [71
36 t of the thyroid-specific agents, iodine and methimazole (MMI) on thyroid graft survival in BB/Wor ra
41 en is controversial because the usual drugs--methimazole or carbimazole--are occasionally teratogenic
42 e probed the hypothesis that a derivative of methimazole, phenyl methimazole (compound 10), can reduc
44 with radioactive iodine was more likely than methimazole therapy alone to be associated with the appe